Expression of adhesion molecules on myeloma cells

Japanese Journal of Cancer Research

Volumn 87, Issue 8, 1996, Pages 837-842

  Tatsumi, Tetsuya ^a   Shimazaki, Chihiro ^a   Goto, Hideo ^a   Araki, Shin Ichi ^a   Sudo, Yoshikazu ^a   Yamagata, Noboru ^a   Ashihara, Eishi ^a   Inaba, Tohru ^a   Fujita, Naohisa ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Adhesion molecule; Immunophenotypic analysis; Myeloma cell

Indexed keywords

ANTIBODY; BETA1 INTEGRIN; CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; NERVE CELL ADHESION MOLECULE;

ARTICLE; CELL INTERACTION; CELL LINE; CELL MIGRATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL;

EID: 10144233477     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb02108.x     Document Type: Article

References (37)

1. Bergui, L., Schema, M., Gaidano, G., Riva, M. and Caligalis-Cappio, F. Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J. Exp. Med., 170, 613-619 (1989).
2. Goto, H., Shimazaki, C., Ashihara, E., Ohkawa, K., Oku, N., Inaba, T., Murakami, S., Fujita, N. and Nakagawa, M. Effects of interleukin-3 and interleukin-6 on peripheral blood cells from multiple myeloma patients and their clinical significance. Acta Haematol., 88, 129-135 (1992).
3. + peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain. Blood, 85, 436-447 (1995).
4. Caligaris-Cappio, F., Bergui, L., Gregoretti, M. G., Gaidano, G., Gaboli, M., Schena, M., Zsllone, A. Z. and Marchisio, P. C. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood, 77, 2688-2693 (1991).
5. Roldan, E., Garcia-Pardo, A. and Brieva, J. A. VLA-4-fibronection interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion. J. Exp. Med., 175, 1739-1747 (1992).
6. Tang, J., Scott, G. and Ryan, D. H. Subpopulations of bone marrow fibroblasts support VLA-4-mediated migration of B-cell precursors. Blood, 82, 3415-3423 (1993).
7. Kalasz, V., Pap, T., Csanaky, G. and Kelenyi, G. Endothelial cell receptors on leukemic cells. Leuk. Res., 13, 863-868 (1989).
8. Tsutani, H., Sugiyama, T., Shimizu, S., Iwasaki, H., Ueda, T., Ozaki, K., Konda, S. and Nakamura, T. Discordant LFA-1/ICAM-1 expression in a case of secondary plasma cell leukemia associated with subcutaneous plasmacytoma. Am. J. Hematol., 42, 299-304 (1993).
9. Uchiyama, H., Barut, B. A., Mohrbacher, A. F., Chauhan, D. and Anderson, K. C. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interieukin-6 secretion. Blood, 82, 3712-3720 (1993).
10. Lokhorst, H. M., Lamme, T., De Smet, M., Klein, S., De Weger, R. A., van Oers, R. and Bloem, A. C. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood, 84, 2269-2277 (1994).
11. van Camp, B., Durie, B. G. M., Spier, C., De Wael, E. M., van Riet, I., Vela, E., Frutigar, Y., Richter, L. and Grogan, T. M. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood, 76, 377-382 (1990).
12. Drach, L., Gattringer, C. and Huber, H. Expression of the neural cell adhesion molecule (CD56) by human myeloma cells. Clin. Exp. Immunol., 83, 418-422 (1991).
13. van Riet, I., De Waele, M., Remels, L., Lacor, P., Schots, R. and van Camp, B. Expression of cytoadhesion molecules (CD56, CD54, CD18, CD29) by myeloma plasma cells. Br. J. Haematol., 79, 421-427 (1991).
14. Barker, H. F., Hamilton, M. S., Ball, J., Drew, M. and Franklin, I. M. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells. Br. J. Haematol., 81, 331-335 (1992).
15. + is the common phenotype of myeloma cells. Ann. Hematol., 64, 132-139 (1992).
16. Uchiyama, H., Barut, B. A., Chauhan, D., Cannistra, S. A. and Anderson, K. C. Characterization of adhesion molecules on human myeloma cell lines. Blood, 80, 2306-2314 (1992).
17. Pellat-Deceunynck, C., Brille, S., Puthier, D., Rapp, M. J., Harousseau, J. L., Bataille, R. and Amiot, M. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. Cancer Res., 55, 3647-3653 (1995).
18. Vacca, A., Di Loreto, M., Ribatti, D., Di Stefano, R., Gadaleta-Caldarola, G., Iodice, G., Caloro, D. and Dammacco, F. Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am. J. Hematol., 50, 9-14 (1995).
19. Jalkanen, S., Joensuu, H. and Klemi, P. Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma. Blood, 75, 1549-1556 (1990).
20. Stauder, R., Greil, R., Schulz, T. F., Thaler, J., Gattringer, C., Radaskiewicz, T., Dierich, M. P. and Huber, H. Expression of leucocyte function-associated antigen-1 and 7F 7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin's lymphomas and leukaemias: possible influence on growth pattern and leukaemic behavior. Clin. Exp. Immunol., 77, 234-238 (1989).
21. Horst, E., Meijer, C. J. L. M., Radaskiewicz, T., Ossekoppele, G. J., van Krieken, J. H. J. M. and Pals, S. T. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia, 4, 595-599 (1990).
22. Suchman, A. L., Coleman, M., Mouradian, J. A., Wolf, D. J. and Saletan, S. Aggressive plasma cell myeloma: a terminal phase. Arch. Intern. Med., 141, 1315-1320 (1981).
23. Durie, B. G. M. and Salmon, S. E. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842-854 (1975).
24. Shimazaki, C., Ashihara, E., Ohkawa, K., Goto, H., Oku, N., Inaba, T., Ito, K., Fujita, N., Nakagawa, M. and Kawa, K. Establishment of myeloma cell line from a patient with aggressive myeloma. Int. J. Hematol., 55 (Suppl. 1), 242 (1992).
25. Goto, H., Shimazaki, C., Tatsumi, T., Yamagata, N., Fujita, N., Tsuchiya, M., Koishihara, Y., Ohsugi, Y. and Nakagawa, M. Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism. Leukemia, 9, 711-718 (1995).
26. Greipp, P. R., Raymond, N. M., Kyle, R. A. and O'Fallon, W. M. Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood, 65, 305-310 (1985).
27. Ruiz-Arguelles, G. J., Katzmann, J. A., Greipp, P. R., Gonchoroff, N., Garton, J. P. and Kyle, R. A. Multiple myeloma: circulating lymphocytes that express plasma cell antigens. Blood, 64, 352-356 (1984).
28. Shimazaki, C., Fried, J., Perez, A. G., Scheinberg, D. A., Atzpodien, J., Wang, C. Y., Wisniewolski, R. and Clarkson, B. D. Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma. Acta Haematol., 83, 123-129 (1990).
29. Harada, H., Kawano, M. M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H. and Kuramoto, A. Phenotypic differences of normal plasma cells from mature myeloma cells. Blood, 81, 2658-2663 (1993).
30. Kawano, M. M., Huang, N., Harada, H., Harada, Y., Sakai, A., Tanaka, H., Iwato, K. and Kuramoto, A. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood, 82, 564-570 (1993).
31. Huang, N., Kawano, M. M., Harada, H., Harada, Y., Sakai, A., Kuramoto, A. and Niwa, O. Heterogeneous expression of a novel MPC-1 antigen on myeloma cells: possible involvement of MPC-1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells. Blood, 82, 3721-3729 (1993).
32. Ahsmann, E. L. M., Lokhorst, H. M., Dekker, A. W. and Bloem, A. C. Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood, 79, 2068-2075 (1992).
33. Kim, I., Uchiyama, H., Chauhan, D. and Anderson, K. C. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines. Br. J. Haematol., 87, 483-493 (1994).
34. Okada, T. and Hawley, R. G. Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elements. Int. J. Cancer, 63, 823-830 (1995).
35. Yamagata, N., Shimazaki, C., Tatsumi, T., Goto, H. and Nakagawa, M. Cell adhesion receptors on neoplastic plasma cells (author's reply). Am. J. Hematol., 49, 361-363 (1995).
36. Schwab, G., Siegall, C. B., Aaden, L. A., Neckers, L. M. and Nordan, R. P. Characterization of an interleukin-6-mediated autocrine growth loop in the myeloma cell lines, U266. Blood, 77, 587-593 (1991).
37. Klein, B., Zhang, X. G., Jourdan, M., Content, J., Houssiau, F., Aadan, L., Piechaczyk, M. and Bataille, R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood, 73, 517-562 (1989).